Sunday House Call, #671,  October 14, 2018: Cannabidiol: Mainstream companies will market the hype, ignore the evidence, and the fail to acknowledge the unknown. Just look at the supplement industry.

Dr. Barry Dworkin

Sunday House Call, #671,  October 14, 2018: Cannabidiol: They will market the hype, ignore the evidence, and the fail to acknowledge the unknown.

Topics today include:

I discuss the latest research on the effects of marijuana on the 13-17 year-old adolescents, the signs that an explosion of marketing and consumer products from edibles to creams to cosmetics seems to be ramping up based on anecdotal evidence of the health benefits of cannabidiol, and a brief review of how it interacts with our bodies.

Your calls about:

  • calcium level
  • CBD oil
  • and more

[display_podcast]

 

Reference:

Morin JG, Afzali MH, Bourque J, et al. A Population-Based Analysis of the Relationship Between Substance Use and Adolescent Cognitive DevelopmentThe American Journal of Psychiatry. Published online October 3 2018

Related posts:

  1. Sunday House Call #642,  February 18, 2018: Systematic review gives straight dope on medical use of cannabis. Let the Backfire-Effect-Games begin.
  2. Sunday House Call, #664,  August 26, 2018: Bartender! A shot of vodka with a coconut oil chaser.
  3. Sunday House Call, #665,  September 2, 2018: Cannabis Marketing Crusades: Some journalists and many companies promoting the hype without evidence
  4. Sunday House Call, #704, July 29, 2019: CBD oil for pain? Not so fast. It may be the flavonoids! A post hoc ergo propter hoc adventure